Ovarian Cancer Patients Can Benefit From Personalised Vaccine, Adoptive T Cell Therapy — Study

NEW YORK — Combining the personalised cancer vaccine with adoptive T cell therapy (ACT) can benefit patients with late-stage, drug-resistant ovarian cancer, a

Related Keywords

George Coukos ,Lana Kandalaft ,Sara Bobisse , ,Nature Cancer ,